{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:53:10Z","timestamp":1790833990922,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To evaluate the cost effectiveness of sequential medical and surgical therapy for the treatment of endometriosis-related dysmenorrhea.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>A cost-effectiveness model was created to compare three stepwise medical and surgical treatment strategies compared with immediate surgical management for dysmenorrhea using a health care payor perspective. A theoretical study cohort was derived from the estimated number of reproductive age (18\u201345) women in the United States with endometriosis-related dysmenorrhea. The treatment strategies modeled were: strategy 1) nonsteroidal antiinflammatory drugs (NSAIDs) followed by surgery; strategy 2) NSAIDs, then short-acting reversible contraceptives or long-acting reversible contraceptives (LARCs) followed by surgery; strategy 3) NSAIDs, then a short-acting reversible contraceptive or LARC, then a LARC or gonadotropin-releasing hormone modulator followed by surgery; strategy 4) proceeding directly to surgery. Probabilities, utilities, and costs were derived from the literature. Outcomes included cost, quality-adjusted life years (QALYs), and incremental cost-effectiveness ratios. Univariate, bivariate, and multivariate sensitivity analyses were performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>In this theoretical cohort of 4,817,894 women with endometriosis-related dysmenorrhea, all medical and surgical treatment strategies were cost effective at a standard willingness-to-pay threshold of $100,000 per QALY gained when compared with surgery alone. Strategy 2 was associated with the lowest cost per QALY gained ($1,155). Requiring a trial of a third medication before surgery would cost an additional $257 million, compared with proceeding to surgery after failing two medical treatments. The probability of improvement with surgery would need to exceed 83% for this to be the preferred first-line approach.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>All sequential medical and surgical management strategies for endometriosis-related dysmenorrhea were cost effective when compared with surgery alone. A trial of hormonal management after NSAIDs, before proceeding to surgery, may provide cost savings. Delaying surgical management in an individual with pain refractory to more than three medications may decrease quality of life and increase cost.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000004536","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T00:34:59Z","timestamp":1631234099000},"page":"557-564","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Stepwise Approach to the Management of Endometriosis-Related Dysmenorrhea"],"prefix":"10.1097","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7340-6007","authenticated-orcid":false,"given":"Jacqueline A.","family":"Bohn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley A.","family":"Bullard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria I.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda M.","family":"Ecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,9,8]]},"reference":[{"key":"R1-20250430","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1159\/000452660","article-title":"Prevalence and symptomatic burden of diagnosed endometriosis in the United States: national estimates from a cross-sectional survey of 59,411 women","volume":"82","author":"Fuldeore","year":"2017","journal-title":"Gynecol Obstet Invest"},{"key":"R2-20250430","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/AOG.0000000000002469","article-title":"Clinical management of endometriosis","volume":"131","author":"Tommaso","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R3-20250430","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.fertnstert.2014.10.011","article-title":"Healthcare utilization and costs in women diagnosed with endometriosis before and after diagnosis: a longitudinal analysis of claims databases","volume":"103","author":"Fuldeore","year":"2015","journal-title":"Fertil Steril"},{"key":"R4-20250430","doi-asserted-by":"crossref","first-page":"354.e1","DOI":"10.1016\/j.ajog.2018.12.039","article-title":"Clinical diagnosis of endometriosis: a call to action","volume":"220","author":"Agarwal","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"R5-20250430","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrendo.2013.255","article-title":"Endometriosis: pathogenesis and treatment","volume":"10","author":"Vercellini","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"R6-20250430","doi-asserted-by":"crossref","first-page":"324.e1","DOI":"10.1016\/j.ajog.2017.12.007","article-title":"Spectrum of symptoms in women diagnosed with endometriosis during adolescence vs adulthood","volume":"218","author":"DiVasta","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R7-20250430","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/humrep\/dev335","article-title":"The direct and indirect costs associated with endometriosis: a systematic literature review","volume":"31","author":"Soliman","year":"2016","journal-title":"Hum Reprod"},{"key":"R8-20250430","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.fertnstert.2011.05.090","article-title":"Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries","volume":"96","author":"Nnoaham","year":"2011","journal-title":"Fertil Steril"},{"key":"R9-20250430","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.fertnstert.2007.11.020","article-title":"Diagnostic experience among 4,334 women reporting surgically diagnosed endometriosis","volume":"91","author":"Greene","year":"2009","journal-title":"Fertil Steril"},{"key":"R10-20250430","doi-asserted-by":"crossref","first-page":"F1000","DOI":"10.12688\/f1000research.14817.1","article-title":"Endometriosis: advances and controversies in classification, pathogenesis, diagnosis, and treatment","volume":"8","author":"Rolla","year":"2019","journal-title":"F1000Res"},{"key":"R11-20250430","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMcp1000274","article-title":"Clinical practice. Endometriosis","volume":"362","author":"Giudice","year":"2010","journal-title":"N Engl J Med"},{"key":"R12-20250430","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/humrep\/des073","article-title":"The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres","volume":"27","author":"Simoens","year":"2012","journal-title":"Hum Reprod"},{"key":"R13-20250430","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s12325-018-0667-3","article-title":"Real-world evaluation of direct and indirect economic burden among endometriosis patients in the United States","volume":"35","author":"Soliman","year":"2018","journal-title":"Adv Ther"},{"key":"R14-20250430","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.fertnstert.2017.03.020","article-title":"Incremental direct and indirect cost burden attributed to endometriosis surgeries in the United States","volume":"107","author":"Soliman","year":"2017","journal-title":"Fertil Steril"},{"key":"R15-20250430","first-page":"566","article-title":"Health care utilization and costs associated with endometriosis among women with Medicaid insurance","volume":"25","author":"Soliman","year":"2019","journal-title":"J Manag Care Spec Pharm"},{"key":"R18-20250430","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0301-2115(99)00131-1","article-title":"Estroprogestin vs. gonadotrophin agonists plus estroprogestin in the treatment of endometriosis-related pelvic pain: a randomized trial. Gruppo Italiano per lo Studio dell'Endometriosi","volume":"88","author":"Parazzini","year":"2000","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R19-20250430","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.fertnstert.2004.07.961","article-title":"Serum and peritoneal fluid levels of levonorgestrel in women with endometriosis who were treated with an intrauterine contraceptive device containing levonorgestrel","volume":"83","author":"Lockhat","year":"2005","journal-title":"Fertil Steril"},{"key":"R20-20250430","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/humrep\/dei290","article-title":"Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain","volume":"21","author":"Crosignani","year":"2006","journal-title":"Hum Reprod"},{"key":"R21-20250430","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1056\/NEJMoa1700089","article-title":"Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist","volume":"377","author":"Taylor","year":"2017","journal-title":"N Engl J Med"},{"key":"R22-20250430","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jmig.2018.08.005","article-title":"Patient quality of life and symptoms after surgical treatment for endometriosis","volume":"26","author":"Comptour","year":"2019","journal-title":"J Minim Invasive Gynecol"},{"key":"R23-20250430","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2217\/cer-2018-0124","article-title":"Cost-effectiveness of elagolix versus leuprolide acetate for treating moderate-to-severe endometriosis pain in the USA","volume":"8","author":"Wang","year":"2019","journal-title":"J Comp Eff Res"},{"key":"R24-20250430","doi-asserted-by":"crossref","first-page":"508.e1","DOI":"10.1016\/j.ajog.2018.01.025","article-title":"Cost-effectiveness of emergency contraception options over 1 year","volume":"218","author":"Bellows","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R30-20250430","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/jama.1996.03540160061034","article-title":"Recommendations for reporting cost-effectiveness analyses. Panel on cost-effectiveness in health and medicine","volume":"276","author":"Siegel","year":"1996","journal-title":"JAMA"},{"key":"R31-20250430","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJMp1405158","article-title":"Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold","volume":"371","author":"Neumann","year":"2014","journal-title":"N Engl J Med"},{"key":"R32-20250430","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.contraception.2019.05.004","article-title":"Ulipristal acetate compared to levonorgestrel emergency contraception among current oral contraceptive users: a cost-effectiveness analysis","volume":"100","author":"Bullard","year":"2019","journal-title":"Contraception"},{"key":"R33-20250430","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/AOG.0000000000002483","article-title":"Twenty-week abortion bans on pregnancies with a congenital diaphragmatic hernia: a cost-effectiveness analysis","volume":"131","author":"Bullard","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R34-20250430","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3390\/medicina55070372","article-title":"Is scientific medical literature related to endometriosis treatment evidence-based? A systematic review on methodological quality of randomized clinical trials","volume":"55","author":"Capra\u015f","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"R35-20250430","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1055\/s-0033-1350890","article-title":"Surgical therapy of endometriosis: challenges and controversies","volume":"73","author":"Rimbach","year":"2013","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"R36-20250430","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/AOG.0000000000003461","article-title":"Optimal management of endometriosis and pain","volume":"134","author":"Nezhat","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R37-20250430","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3109\/13645706.2011.617758","article-title":"Effects of laparoscopic radical surgery for deep endometriosis on endometriosis-related pelvic pain","volume":"21","author":"Hidaka","year":"2012","journal-title":"Minim Invasive Ther Allied Technol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004536","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T06:46:12Z","timestamp":1746081972000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004536"}},"subtitle":["A Cost-Effectiveness Analysis"],"short-title":[],"issued":{"date-parts":[[2021,9,8]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004536","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,8]]},"assertion":[{"value":"2021-03-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}